Neurocysticercosis: A rare disorder
1 PharmD Intern, Department of Pharmacy Practice, JSS College of Pharmacy, Ooty, India.
2 Faculty of Health Sciences, School of Pharmacy, JSS Academy of Higher Education and Research, Mauritius.
Research Article
World Journal of Advanced Research and Reviews, 2021, 09(01), 286-291
Article DOI: 10.30574/wjarr.2021.9.1.0030
Publication history:
Received on 17 January 2021; revised on 24 January 2021; accepted on 26 January 2021
Abstract:
Neurocysticercosis (NCC) is a rare central nervous system infection that is preventable and is caused by the Taenia solium tapeworm larval stage. This disorder is the world’s most common cause of acquired epilepsy and a significant cause of neurological morbidity. This disease is pleomorphic due to several complex factors such as cysticerci characteristics, stages of development, and many more which leads to difficulties in inaccurate diagnosis and adequate stage-wise care. The introduction of cystidical medications, however, has led to a stronger prognosis of NCC-affected patients with an increase in the patient’s clinical course of the disease. After diagnosis most seizure patients do not experience epilepsy. Since Neurocysticercosis remains a neglected tropical disease, the management, and prevention of T. so ilium transmission and strategies for eradicating NCC from endemic areas should be highlighted and prioritized in global healthcare to minimize the significant burden on healthcare and the economy.
Keywords:
Neurocysticercosis; Healthcare; Tropical; Neglected
Full text article in PDF:
Copyright information:
Copyright © 2021 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0